← Back to Search

Other

Dextrose Injection for PTSD

N/A
Recruiting
Led By Kenneth D Reeves, M.D.
Research Sponsored by Dr. Dean Reeves Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must have chronic pain ≤ 5/10
Must have tried 2 or more medications for treatment of PTSD symptoms
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will compare the effects of dextrose injection on reducing anxiety, brain fog, and depression in patients with PTSD.

Who is the study for?
This trial is for adults with PTSD who drink less than three alcoholic drinks daily, don't take narcotics, and aren't in other PTSD studies. Participants need reliable transport, computer skills, no life-threatening illness or major stressors that could affect the study. They must live near specified locations in Canada or Hong Kong, provide contact details, commit to a year-long study including possible usual care for 3 months, have had symptoms over a year with moderate pain levels at most.Check my eligibility
What is being tested?
The trial tests cervical plexus hydrodissection with D5W (a dextrose solution) against a waiting period with usual care for PTSD patients. It aims to see if this injection can reduce anxiety and improve mental health symptoms compared to standard treatments after an initial delay.See study design
What are the potential side effects?
Potential side effects of the dextrose injection may include discomfort at the injection site, bruising, nerve irritation leading to temporary increased pain or numbness around the neck area where the shot is given.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My chronic pain is mild, at or below 5 out of 10.
Select...
I have tried at least 2 medications for PTSD.
Select...
I do not take daily painkillers.
Select...
I have had symptoms for over a year.
Select...
I am willing to follow the usual care treatment for 3 months.
Select...
I do not have any major surgeries planned.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Consent rate
Data Capture rate
Satisfaction rating
Secondary outcome measures
HADS scale
PCL-C Score

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BCPHD-D5W with usual careExperimental Treatment1 Intervention
Bilateral cervical plexus hydrodissection with D5W (BCPHD-D5W) at 0, 2, 4, and 8 weeks. All helpful treatment methods already underway are continued. Other new treatment methods are discouraged.
Group II: Waiting period with usual careActive Control1 Intervention
All helpful treatment methods already underway are continued. Other new treatment methods are discouraged.

Find a Location

Who is running the clinical trial?

Stanley Lam, M.D.UNKNOWN
Francois Louw, M.DUNKNOWN
Jannice Bowler, M.D.UNKNOWN

Media Library

BCPHD with D5W (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04421573 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Waiting period with usual care, BCPHD-D5W with usual care
Post-Traumatic Stress Disorder Clinical Trial 2023: BCPHD with D5W Highlights & Side Effects. Trial Name: NCT04421573 — N/A
BCPHD with D5W (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04421573 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrollments for this medical research project?

"Unfortunately, this study is not currently enrolling patients. It was published on November 1st 2021 and last altered on August 30th 2021. Nevertheless, there are 317 distinct trials that have openings for participants at present."

Answered by AI

Am I eligible to join this research study?

"Candidates for this trial should have a diagnosis of posttraumatic stress disorder (PTSD) and be between the ages 19 to 90. Approximately 120 patients will be included in the study."

Answered by AI

What aims are being sought through this scientific experiment?

"The principal aim of this research trial, which is expected to conclude in approximately 3 months' time, will be measured by the Hospital Anxiety and Depression scale. Additionally, a 0-10 Numerical Rating Scale for Anxiety—where "0" denotes no anxiety and "10" implies extreme distress—and EuroQOL-5D-5L + C scale (which measures general quality of life on a range from 1 to 5) as well as Satisfaction with comfort of procedure using another 0-10 numerical rating system shall also be gauged. A reduction in scores across all evaluations would indicate improvement."

Answered by AI

Is this research protocol open to participants aged 75 and older?

"This medical experiment is recruiting participants aged 19 and over, up to the age of 90."

Answered by AI

Who else is applying?

What state do they live in?
New York
Kansas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~16 spots leftby Oct 2026